nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.457	1	CrCrCtD
Vorinostat—HDAC4—nephron tubule—type 2 diabetes mellitus	0.00335	0.0311	CbGeAlD
Vorinostat—HDAC6—cortex of kidney—type 2 diabetes mellitus	0.00332	0.0309	CbGeAlD
Vorinostat—HDAC3—islet of Langerhans—type 2 diabetes mellitus	0.00317	0.0295	CbGeAlD
Vorinostat—HDAC8—cardiovascular system—type 2 diabetes mellitus	0.00309	0.0288	CbGeAlD
Vorinostat—HDAC6—adipose tissue—type 2 diabetes mellitus	0.00307	0.0286	CbGeAlD
Vorinostat—HDAC8—kidney—type 2 diabetes mellitus	0.00303	0.0281	CbGeAlD
Vorinostat—NCOR1—nephron tubule—type 2 diabetes mellitus	0.00291	0.0271	CbGeAlD
Vorinostat—HDAC1—islet of Langerhans—type 2 diabetes mellitus	0.0029	0.027	CbGeAlD
Vorinostat—HDAC4—cortex of kidney—type 2 diabetes mellitus	0.00286	0.0266	CbGeAlD
Vorinostat—HDAC9—islet of Langerhans—type 2 diabetes mellitus	0.00286	0.0266	CbGeAlD
Vorinostat—HDAC8—adipose tissue—type 2 diabetes mellitus	0.00273	0.0254	CbGeAlD
Vorinostat—HDAC3—retina—type 2 diabetes mellitus	0.00271	0.0252	CbGeAlD
Vorinostat—HDAC4—adipose tissue—type 2 diabetes mellitus	0.00265	0.0246	CbGeAlD
Vorinostat—HDAC11—kidney—type 2 diabetes mellitus	0.00264	0.0245	CbGeAlD
Vorinostat—NCOR1—cardiovascular system—type 2 diabetes mellitus	0.00262	0.0243	CbGeAlD
Vorinostat—NCOR1—kidney—type 2 diabetes mellitus	0.00256	0.0238	CbGeAlD
Vorinostat—HDAC3—nephron tubule—type 2 diabetes mellitus	0.00255	0.0237	CbGeAlD
Vorinostat—NCOR1—cortex of kidney—type 2 diabetes mellitus	0.00249	0.0232	CbGeAlD
Vorinostat—HDAC1—retina—type 2 diabetes mellitus	0.00248	0.0231	CbGeAlD
Vorinostat—HDAC11—adipose tissue—type 2 diabetes mellitus	0.00238	0.0221	CbGeAlD
Vorinostat—HDAC1—nephron tubule—type 2 diabetes mellitus	0.00234	0.0217	CbGeAlD
Vorinostat—NCOR1—adipose tissue—type 2 diabetes mellitus	0.00231	0.0215	CbGeAlD
Vorinostat—HDAC9—nephron tubule—type 2 diabetes mellitus	0.0023	0.0214	CbGeAlD
Vorinostat—HDAC3—pancreas—type 2 diabetes mellitus	0.00223	0.0207	CbGeAlD
Vorinostat—HDAC3—cortex of kidney—type 2 diabetes mellitus	0.00219	0.0203	CbGeAlD
Vorinostat—HDAC6—liver—type 2 diabetes mellitus	0.00216	0.02	CbGeAlD
Vorinostat—HDAC1—cardiovascular system—type 2 diabetes mellitus	0.0021	0.0195	CbGeAlD
Vorinostat—HDAC9—cardiovascular system—type 2 diabetes mellitus	0.00207	0.0192	CbGeAlD
Vorinostat—HDAC1—kidney—type 2 diabetes mellitus	0.00206	0.0191	CbGeAlD
Vorinostat—HDAC1—pancreas—type 2 diabetes mellitus	0.00204	0.019	CbGeAlD
Vorinostat—HDAC3—adipose tissue—type 2 diabetes mellitus	0.00202	0.0188	CbGeAlD
Vorinostat—HDAC9—pancreas—type 2 diabetes mellitus	0.00201	0.0187	CbGeAlD
Vorinostat—HDAC1—cortex of kidney—type 2 diabetes mellitus	0.002	0.0186	CbGeAlD
Vorinostat—HDAC9—cortex of kidney—type 2 diabetes mellitus	0.00197	0.0183	CbGeAlD
Vorinostat—HDAC8—liver—type 2 diabetes mellitus	0.00191	0.0178	CbGeAlD
Vorinostat—HDAC4—liver—type 2 diabetes mellitus	0.00186	0.0173	CbGeAlD
Vorinostat—HDAC1—adipose tissue—type 2 diabetes mellitus	0.00185	0.0172	CbGeAlD
Vorinostat—HDAC9—adipose tissue—type 2 diabetes mellitus	0.00182	0.0169	CbGeAlD
Vorinostat—NCOR1—liver—type 2 diabetes mellitus	0.00162	0.015	CbGeAlD
Vorinostat—HDAC2—islet of Langerhans—type 2 diabetes mellitus	0.00146	0.0136	CbGeAlD
Vorinostat—HDAC3—liver—type 2 diabetes mellitus	0.00142	0.0132	CbGeAlD
Vorinostat—HDAC1—liver—type 2 diabetes mellitus	0.0013	0.0121	CbGeAlD
Vorinostat—HDAC2—retina—type 2 diabetes mellitus	0.00125	0.0116	CbGeAlD
Vorinostat—HDAC2—nephron tubule—type 2 diabetes mellitus	0.00118	0.0109	CbGeAlD
Vorinostat—HDAC2—cardiovascular system—type 2 diabetes mellitus	0.00106	0.00982	CbGeAlD
Vorinostat—HDAC2—kidney—type 2 diabetes mellitus	0.00103	0.00961	CbGeAlD
Vorinostat—HDAC2—pancreas—type 2 diabetes mellitus	0.00103	0.00955	CbGeAlD
Vorinostat—HDAC2—cortex of kidney—type 2 diabetes mellitus	0.00101	0.00936	CbGeAlD
Vorinostat—HDAC2—adipose tissue—type 2 diabetes mellitus	0.000931	0.00866	CbGeAlD
Vorinostat—HDAC2—liver—type 2 diabetes mellitus	0.000653	0.00607	CbGeAlD
Vorinostat—Angioedema—Glyburide—type 2 diabetes mellitus	0.000383	0.00204	CcSEcCtD
Vorinostat—Nausea—Acarbose—type 2 diabetes mellitus	0.000382	0.00204	CcSEcCtD
Vorinostat—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.000382	0.00204	CcSEcCtD
Vorinostat—Constipation—Glipizide—type 2 diabetes mellitus	0.00038	0.00203	CcSEcCtD
Vorinostat—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00038	0.00203	CcSEcCtD
Vorinostat—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000375	0.002	CcSEcCtD
Vorinostat—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000375	0.002	CcSEcCtD
Vorinostat—Blood creatinine increased—Ramipril—type 2 diabetes mellitus	0.000373	0.00199	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000373	0.00199	CcSEcCtD
Vorinostat—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000373	0.00199	CcSEcCtD
Vorinostat—Infection—Bromocriptine—type 2 diabetes mellitus	0.000372	0.00198	CcSEcCtD
Vorinostat—Nausea—Nateglinide—type 2 diabetes mellitus	0.000369	0.00197	CcSEcCtD
Vorinostat—Shock—Bromocriptine—type 2 diabetes mellitus	0.000368	0.00196	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000367	0.00196	CcSEcCtD
Vorinostat—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000367	0.00196	CcSEcCtD
Vorinostat—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000367	0.00196	CcSEcCtD
Vorinostat—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000364	0.00194	CcSEcCtD
Vorinostat—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000362	0.00193	CcSEcCtD
Vorinostat—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.00036	0.00192	CcSEcCtD
Vorinostat—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000359	0.00192	CcSEcCtD
Vorinostat—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000359	0.00192	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000358	0.00191	CcSEcCtD
Vorinostat—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000357	0.00191	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000357	0.0019	CcSEcCtD
Vorinostat—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000357	0.0019	CcSEcCtD
Vorinostat—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000356	0.0019	CcSEcCtD
Vorinostat—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.000356	0.0019	CcSEcCtD
Vorinostat—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000353	0.00189	CcSEcCtD
Vorinostat—Alopecia—Valsartan—type 2 diabetes mellitus	0.000351	0.00187	CcSEcCtD
Vorinostat—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000348	0.00186	CcSEcCtD
Vorinostat—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000347	0.00185	CcSEcCtD
Vorinostat—Alopecia—Orlistat—type 2 diabetes mellitus	0.000347	0.00185	CcSEcCtD
Vorinostat—Angioedema—Gliclazide—type 2 diabetes mellitus	0.000344	0.00183	CcSEcCtD
Vorinostat—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000341	0.00182	CcSEcCtD
Vorinostat—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000338	0.00181	CcSEcCtD
Vorinostat—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000337	0.0018	CcSEcCtD
Vorinostat—Headache—Repaglinide—type 2 diabetes mellitus	0.000336	0.0018	CcSEcCtD
Vorinostat—Shock—Glyburide—type 2 diabetes mellitus	0.000336	0.0018	CcSEcCtD
Vorinostat—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.000336	0.00179	CcSEcCtD
Vorinostat—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000336	0.00179	CcSEcCtD
Vorinostat—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000335	0.00179	CcSEcCtD
Vorinostat—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000334	0.00178	CcSEcCtD
Vorinostat—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000332	0.00177	CcSEcCtD
Vorinostat—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000331	0.00176	CcSEcCtD
Vorinostat—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000328	0.00175	CcSEcCtD
Vorinostat—Cough—Gliclazide—type 2 diabetes mellitus	0.000328	0.00175	CcSEcCtD
Vorinostat—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000327	0.00174	CcSEcCtD
Vorinostat—Anorexia—Glyburide—type 2 diabetes mellitus	0.000326	0.00174	CcSEcCtD
Vorinostat—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000325	0.00173	CcSEcCtD
Vorinostat—Chills—Metformin—type 2 diabetes mellitus	0.000324	0.00173	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000323	0.00172	CcSEcCtD
Vorinostat—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000322	0.00172	CcSEcCtD
Vorinostat—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000322	0.00172	CcSEcCtD
Vorinostat—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00032	0.00171	CcSEcCtD
Vorinostat—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00032	0.00171	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.00032	0.00171	CcSEcCtD
Vorinostat—Nausea—Repaglinide—type 2 diabetes mellitus	0.000319	0.0017	CcSEcCtD
Vorinostat—Asthenia—Glipizide—type 2 diabetes mellitus	0.000319	0.0017	CcSEcCtD
Vorinostat—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000318	0.0017	CcSEcCtD
Vorinostat—Angioedema—Valsartan—type 2 diabetes mellitus	0.000316	0.00169	CcSEcCtD
Vorinostat—Pruritus—Glipizide—type 2 diabetes mellitus	0.000314	0.00168	CcSEcCtD
Vorinostat—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000313	0.00167	CcSEcCtD
Vorinostat—Angioedema—Orlistat—type 2 diabetes mellitus	0.000312	0.00167	CcSEcCtD
Vorinostat—Syncope—Valsartan—type 2 diabetes mellitus	0.00031	0.00165	CcSEcCtD
Vorinostat—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000308	0.00164	CcSEcCtD
Vorinostat—Chills—Irbesartan—type 2 diabetes mellitus	0.000306	0.00163	CcSEcCtD
Vorinostat—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000305	0.00163	CcSEcCtD
Vorinostat—Infection—Gliclazide—type 2 diabetes mellitus	0.000305	0.00163	CcSEcCtD
Vorinostat—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000304	0.00162	CcSEcCtD
Vorinostat—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000304	0.00162	CcSEcCtD
Vorinostat—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000303	0.00161	CcSEcCtD
Vorinostat—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000302	0.00161	CcSEcCtD
Vorinostat—Cough—Valsartan—type 2 diabetes mellitus	0.000302	0.00161	CcSEcCtD
Vorinostat—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000301	0.00161	CcSEcCtD
Vorinostat—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000301	0.0016	CcSEcCtD
Vorinostat—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000301	0.0016	CcSEcCtD
Vorinostat—Cough—Orlistat—type 2 diabetes mellitus	0.000298	0.00159	CcSEcCtD
Vorinostat—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000297	0.00159	CcSEcCtD
Vorinostat—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000297	0.00159	CcSEcCtD
Vorinostat—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000297	0.00158	CcSEcCtD
Vorinostat—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000296	0.00158	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000295	0.00158	CcSEcCtD
Vorinostat—Chest pain—Valsartan—type 2 diabetes mellitus	0.000294	0.00157	CcSEcCtD
Vorinostat—Dizziness—Glipizide—type 2 diabetes mellitus	0.000294	0.00157	CcSEcCtD
Vorinostat—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000293	0.00157	CcSEcCtD
Vorinostat—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000291	0.00155	CcSEcCtD
Vorinostat—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000291	0.00155	CcSEcCtD
Vorinostat—Chest pain—Orlistat—type 2 diabetes mellitus	0.000291	0.00155	CcSEcCtD
Vorinostat—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000288	0.00154	CcSEcCtD
Vorinostat—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000286	0.00152	CcSEcCtD
Vorinostat—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000284	0.00152	CcSEcCtD
Vorinostat—Alopecia—Losartan—type 2 diabetes mellitus	0.000284	0.00151	CcSEcCtD
Vorinostat—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000284	0.00151	CcSEcCtD
Vorinostat—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000283	0.00151	CcSEcCtD
Vorinostat—Vomiting—Glipizide—type 2 diabetes mellitus	0.000282	0.00151	CcSEcCtD
Vorinostat—Syncope—Metformin—type 2 diabetes mellitus	0.000282	0.00151	CcSEcCtD
Vorinostat—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000281	0.0015	CcSEcCtD
Vorinostat—Infection—Valsartan—type 2 diabetes mellitus	0.00028	0.0015	CcSEcCtD
Vorinostat—Headache—Glipizide—type 2 diabetes mellitus	0.000278	0.00149	CcSEcCtD
Vorinostat—Shock—Valsartan—type 2 diabetes mellitus	0.000278	0.00148	CcSEcCtD
Vorinostat—Infection—Orlistat—type 2 diabetes mellitus	0.000277	0.00148	CcSEcCtD
Vorinostat—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000277	0.00148	CcSEcCtD
Vorinostat—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000276	0.00147	CcSEcCtD
Vorinostat—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000275	0.00146	CcSEcCtD
Vorinostat—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000274	0.00146	CcSEcCtD
Vorinostat—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000274	0.00146	CcSEcCtD
Vorinostat—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000273	0.00146	CcSEcCtD
Vorinostat—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000271	0.00145	CcSEcCtD
Vorinostat—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000271	0.00145	CcSEcCtD
Vorinostat—Anorexia—Valsartan—type 2 diabetes mellitus	0.000269	0.00143	CcSEcCtD
Vorinostat—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000269	0.00143	CcSEcCtD
Vorinostat—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000268	0.00143	CcSEcCtD
Vorinostat—Chest pain—Metformin—type 2 diabetes mellitus	0.000268	0.00143	CcSEcCtD
Vorinostat—Headache—Pioglitazone—type 2 diabetes mellitus	0.000267	0.00142	CcSEcCtD
Vorinostat—Syncope—Irbesartan—type 2 diabetes mellitus	0.000266	0.00142	CcSEcCtD
Vorinostat—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000266	0.00142	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000265	0.00141	CcSEcCtD
Vorinostat—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000265	0.00141	CcSEcCtD
Vorinostat—Nausea—Glipizide—type 2 diabetes mellitus	0.000264	0.00141	CcSEcCtD
Vorinostat—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000264	0.00141	CcSEcCtD
Vorinostat—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000263	0.0014	CcSEcCtD
Vorinostat—Constipation—Gliclazide—type 2 diabetes mellitus	0.000263	0.0014	CcSEcCtD
Vorinostat—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000261	0.00139	CcSEcCtD
Vorinostat—Headache—Glimepiride—type 2 diabetes mellitus	0.00026	0.00139	CcSEcCtD
Vorinostat—Cough—Irbesartan—type 2 diabetes mellitus	0.000259	0.00138	CcSEcCtD
Vorinostat—Headache—Sitagliptin—type 2 diabetes mellitus	0.000259	0.00138	CcSEcCtD
Vorinostat—Anaemia—Losartan—type 2 diabetes mellitus	0.000258	0.00138	CcSEcCtD
Vorinostat—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000256	0.00137	CcSEcCtD
Vorinostat—Angioedema—Losartan—type 2 diabetes mellitus	0.000255	0.00136	CcSEcCtD
Vorinostat—Infection—Metformin—type 2 diabetes mellitus	0.000255	0.00136	CcSEcCtD
Vorinostat—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000253	0.00135	CcSEcCtD
Vorinostat—Shock—Metformin—type 2 diabetes mellitus	0.000253	0.00135	CcSEcCtD
Vorinostat—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000252	0.00134	CcSEcCtD
Vorinostat—Syncope—Losartan—type 2 diabetes mellitus	0.000251	0.00134	CcSEcCtD
Vorinostat—Leukopenia—Losartan—type 2 diabetes mellitus	0.00025	0.00134	CcSEcCtD
Vorinostat—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000247	0.00132	CcSEcCtD
Vorinostat—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000247	0.00132	CcSEcCtD
Vorinostat—Nausea—Glimepiride—type 2 diabetes mellitus	0.000246	0.00131	CcSEcCtD
Vorinostat—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000246	0.00131	CcSEcCtD
Vorinostat—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000245	0.00131	CcSEcCtD
Vorinostat—Asthenia—Glyburide—type 2 diabetes mellitus	0.000245	0.00131	CcSEcCtD
Vorinostat—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000245	0.00131	CcSEcCtD
Vorinostat—Anorexia—Metformin—type 2 diabetes mellitus	0.000245	0.00131	CcSEcCtD
Vorinostat—Cough—Losartan—type 2 diabetes mellitus	0.000244	0.0013	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000244	0.0013	CcSEcCtD
Vorinostat—Alopecia—Ramipril—type 2 diabetes mellitus	0.000243	0.0013	CcSEcCtD
Vorinostat—Fatigue—Valsartan—type 2 diabetes mellitus	0.000243	0.0013	CcSEcCtD
Vorinostat—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000243	0.0013	CcSEcCtD
Vorinostat—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000242	0.00129	CcSEcCtD
Vorinostat—Pruritus—Glyburide—type 2 diabetes mellitus	0.000242	0.00129	CcSEcCtD
Vorinostat—Constipation—Valsartan—type 2 diabetes mellitus	0.000241	0.00129	CcSEcCtD
Vorinostat—Infection—Irbesartan—type 2 diabetes mellitus	0.000241	0.00129	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000241	0.00128	CcSEcCtD
Vorinostat—Fatigue—Orlistat—type 2 diabetes mellitus	0.00024	0.00128	CcSEcCtD
Vorinostat—Shock—Irbesartan—type 2 diabetes mellitus	0.000239	0.00127	CcSEcCtD
Vorinostat—Chest pain—Losartan—type 2 diabetes mellitus	0.000238	0.00127	CcSEcCtD
Vorinostat—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000238	0.00127	CcSEcCtD
Vorinostat—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000237	0.00127	CcSEcCtD
Vorinostat—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000235	0.00125	CcSEcCtD
Vorinostat—Headache—Bromocriptine—type 2 diabetes mellitus	0.000234	0.00125	CcSEcCtD
Vorinostat—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000234	0.00125	CcSEcCtD
Vorinostat—Dry mouth—Losartan—type 2 diabetes mellitus	0.000233	0.00124	CcSEcCtD
Vorinostat—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000231	0.00123	CcSEcCtD
Vorinostat—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.00023	0.00123	CcSEcCtD
Vorinostat—Infection—Losartan—type 2 diabetes mellitus	0.000227	0.00121	CcSEcCtD
Vorinostat—Shock—Losartan—type 2 diabetes mellitus	0.000224	0.0012	CcSEcCtD
Vorinostat—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000223	0.00119	CcSEcCtD
Vorinostat—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000223	0.00119	CcSEcCtD
Vorinostat—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000222	0.00119	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000222	0.00118	CcSEcCtD
Vorinostat—Fatigue—Metformin—type 2 diabetes mellitus	0.000221	0.00118	CcSEcCtD
Vorinostat—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00022	0.00118	CcSEcCtD
Vorinostat—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00022	0.00118	CcSEcCtD
Vorinostat—Constipation—Metformin—type 2 diabetes mellitus	0.00022	0.00117	CcSEcCtD
Vorinostat—Angioedema—Ramipril—type 2 diabetes mellitus	0.000219	0.00117	CcSEcCtD
Vorinostat—Anorexia—Losartan—type 2 diabetes mellitus	0.000217	0.00116	CcSEcCtD
Vorinostat—Vomiting—Glyburide—type 2 diabetes mellitus	0.000217	0.00116	CcSEcCtD
Vorinostat—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000217	0.00116	CcSEcCtD
Vorinostat—Syncope—Ramipril—type 2 diabetes mellitus	0.000215	0.00115	CcSEcCtD
Vorinostat—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000215	0.00114	CcSEcCtD
Vorinostat—Headache—Glyburide—type 2 diabetes mellitus	0.000214	0.00114	CcSEcCtD
Vorinostat—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000211	0.00112	CcSEcCtD
Vorinostat—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000211	0.00112	CcSEcCtD
Vorinostat—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00021	0.00112	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000209	0.00112	CcSEcCtD
Vorinostat—Cough—Ramipril—type 2 diabetes mellitus	0.000209	0.00112	CcSEcCtD
Vorinostat—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000209	0.00112	CcSEcCtD
Vorinostat—Constipation—Irbesartan—type 2 diabetes mellitus	0.000207	0.00111	CcSEcCtD
Vorinostat—Chest pain—Ramipril—type 2 diabetes mellitus	0.000204	0.00109	CcSEcCtD
Vorinostat—Nausea—Glyburide—type 2 diabetes mellitus	0.000203	0.00108	CcSEcCtD
Vorinostat—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000203	0.00108	CcSEcCtD
Vorinostat—Asthenia—Valsartan—type 2 diabetes mellitus	0.000202	0.00108	CcSEcCtD
Vorinostat—Asthenia—Orlistat—type 2 diabetes mellitus	0.0002	0.00107	CcSEcCtD
Vorinostat—Pruritus—Valsartan—type 2 diabetes mellitus	0.0002	0.00106	CcSEcCtD
Vorinostat—Dry mouth—Ramipril—type 2 diabetes mellitus	0.0002	0.00106	CcSEcCtD
Vorinostat—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000198	0.00106	CcSEcCtD
Vorinostat—Pruritus—Orlistat—type 2 diabetes mellitus	0.000197	0.00105	CcSEcCtD
Vorinostat—Fatigue—Losartan—type 2 diabetes mellitus	0.000197	0.00105	CcSEcCtD
Vorinostat—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000195	0.00104	CcSEcCtD
Vorinostat—Constipation—Losartan—type 2 diabetes mellitus	0.000195	0.00104	CcSEcCtD
Vorinostat—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000193	0.00103	CcSEcCtD
Vorinostat—Shock—Ramipril—type 2 diabetes mellitus	0.000192	0.00103	CcSEcCtD
Vorinostat—Headache—Gliclazide—type 2 diabetes mellitus	0.000192	0.00103	CcSEcCtD
Vorinostat—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000192	0.00102	CcSEcCtD
Vorinostat—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000192	0.00102	CcSEcCtD
Vorinostat—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000191	0.00102	CcSEcCtD
Vorinostat—Dizziness—Valsartan—type 2 diabetes mellitus	0.000187	0.000995	CcSEcCtD
Vorinostat—Anorexia—Ramipril—type 2 diabetes mellitus	0.000186	0.000995	CcSEcCtD
Vorinostat—Dizziness—Orlistat—type 2 diabetes mellitus	0.000184	0.000984	CcSEcCtD
Vorinostat—Asthenia—Metformin—type 2 diabetes mellitus	0.000184	0.000983	CcSEcCtD
Vorinostat—Nausea—Gliclazide—type 2 diabetes mellitus	0.000182	0.000973	CcSEcCtD
Vorinostat—Pruritus—Metformin—type 2 diabetes mellitus	0.000182	0.00097	CcSEcCtD
Vorinostat—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00018	0.000962	CcSEcCtD
Vorinostat—Vomiting—Valsartan—type 2 diabetes mellitus	0.000179	0.000957	CcSEcCtD
Vorinostat—Vomiting—Orlistat—type 2 diabetes mellitus	0.000177	0.000946	CcSEcCtD
Vorinostat—Headache—Valsartan—type 2 diabetes mellitus	0.000177	0.000943	CcSEcCtD
Vorinostat—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000176	0.000938	CcSEcCtD
Vorinostat—Headache—Orlistat—type 2 diabetes mellitus	0.000175	0.000932	CcSEcCtD
Vorinostat—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000174	0.000928	CcSEcCtD
Vorinostat—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000172	0.000915	CcSEcCtD
Vorinostat—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.00017	0.000907	CcSEcCtD
Vorinostat—Dizziness—Metformin—type 2 diabetes mellitus	0.00017	0.000906	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000169	0.000901	CcSEcCtD
Vorinostat—Fatigue—Ramipril—type 2 diabetes mellitus	0.000169	0.0009	CcSEcCtD
Vorinostat—Nausea—Valsartan—type 2 diabetes mellitus	0.000168	0.000894	CcSEcCtD
Vorinostat—Constipation—Ramipril—type 2 diabetes mellitus	0.000167	0.000893	CcSEcCtD
Vorinostat—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000166	0.000885	CcSEcCtD
Vorinostat—Nausea—Orlistat—type 2 diabetes mellitus	0.000166	0.000883	CcSEcCtD
Vorinostat—Asthenia—Losartan—type 2 diabetes mellitus	0.000164	0.000873	CcSEcCtD
Vorinostat—Vomiting—Metformin—type 2 diabetes mellitus	0.000163	0.000872	CcSEcCtD
Vorinostat—Pruritus—Losartan—type 2 diabetes mellitus	0.000161	0.000861	CcSEcCtD
Vorinostat—Headache—Metformin—type 2 diabetes mellitus	0.000161	0.000859	CcSEcCtD
Vorinostat—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00016	0.000855	CcSEcCtD
Vorinostat—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000156	0.000833	CcSEcCtD
Vorinostat—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000155	0.000825	CcSEcCtD
Vorinostat—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000154	0.000822	CcSEcCtD
Vorinostat—Nausea—Metformin—type 2 diabetes mellitus	0.000153	0.000814	CcSEcCtD
Vorinostat—Headache—Irbesartan—type 2 diabetes mellitus	0.000152	0.00081	CcSEcCtD
Vorinostat—Dizziness—Losartan—type 2 diabetes mellitus	0.000151	0.000805	CcSEcCtD
Vorinostat—Vomiting—Losartan—type 2 diabetes mellitus	0.000145	0.000774	CcSEcCtD
Vorinostat—Nausea—Irbesartan—type 2 diabetes mellitus	0.000144	0.000768	CcSEcCtD
Vorinostat—Headache—Losartan—type 2 diabetes mellitus	0.000143	0.000763	CcSEcCtD
Vorinostat—Asthenia—Ramipril—type 2 diabetes mellitus	0.00014	0.000749	CcSEcCtD
Vorinostat—Pruritus—Ramipril—type 2 diabetes mellitus	0.000138	0.000739	CcSEcCtD
Vorinostat—Nausea—Losartan—type 2 diabetes mellitus	0.000136	0.000723	CcSEcCtD
Vorinostat—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000134	0.000714	CcSEcCtD
Vorinostat—Dizziness—Ramipril—type 2 diabetes mellitus	0.000129	0.00069	CcSEcCtD
Vorinostat—Vomiting—Ramipril—type 2 diabetes mellitus	0.000124	0.000664	CcSEcCtD
Vorinostat—Headache—Ramipril—type 2 diabetes mellitus	0.000123	0.000654	CcSEcCtD
Vorinostat—Nausea—Ramipril—type 2 diabetes mellitus	0.000116	0.00062	CcSEcCtD
Vorinostat—HDAC1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.07e-05	4.31e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.07e-05	4.31e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.07e-05	4.3e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.07e-05	4.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—AKT2—type 2 diabetes mellitus	1.06e-05	4.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN2B—type 2 diabetes mellitus	1.06e-05	4.26e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—SRC—type 2 diabetes mellitus	1.06e-05	4.25e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.05e-05	4.22e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.05e-05	4.22e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.05e-05	4.21e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.04e-05	4.18e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APOB—type 2 diabetes mellitus	1.03e-05	4.16e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—ALB—type 2 diabetes mellitus	1.03e-05	4.16e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-05	4.14e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—INS—type 2 diabetes mellitus	1.02e-05	4.12e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.02e-05	4.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.02e-05	4.09e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.02e-05	4.09e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.01e-05	4.07e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—TGFB1—type 2 diabetes mellitus	1.01e-05	4.06e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.01e-05	4.06e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SERPINE1—type 2 diabetes mellitus	1.01e-05	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RELA—type 2 diabetes mellitus	1.01e-05	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—IL6—type 2 diabetes mellitus	1.01e-05	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.01e-05	4.05e-05	CbGpPWpGaD
Vorinostat—HDAC11—Disease—AKT1—type 2 diabetes mellitus	1e-05	4.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—NR3C1—type 2 diabetes mellitus	1e-05	4.03e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1e-05	4.03e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NOS3—type 2 diabetes mellitus	1e-05	4.03e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—PPP2CA—type 2 diabetes mellitus	9.97e-06	4.01e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.91e-06	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.91e-06	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.9e-06	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—EGFR—type 2 diabetes mellitus	9.9e-06	3.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.88e-06	3.98e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.88e-06	3.98e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.87e-06	3.97e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—NOS3—type 2 diabetes mellitus	9.87e-06	3.97e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—LPL—type 2 diabetes mellitus	9.86e-06	3.97e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.84e-06	3.96e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.83e-06	3.96e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.83e-06	3.96e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTGS2—type 2 diabetes mellitus	9.83e-06	3.96e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.66e-06	3.89e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ADCY5—type 2 diabetes mellitus	9.66e-06	3.89e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—C3—type 2 diabetes mellitus	9.65e-06	3.88e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.62e-06	3.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.62e-06	3.87e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3R1—type 2 diabetes mellitus	9.61e-06	3.87e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NOS3—type 2 diabetes mellitus	9.61e-06	3.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.51e-06	3.83e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—SRC—type 2 diabetes mellitus	9.49e-06	3.82e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—SRC—type 2 diabetes mellitus	9.48e-06	3.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—SRC—type 2 diabetes mellitus	9.46e-06	3.81e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—TGFB1—type 2 diabetes mellitus	9.45e-06	3.8e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—INS—type 2 diabetes mellitus	9.42e-06	3.79e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—RELA—type 2 diabetes mellitus	9.42e-06	3.79e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.41e-06	3.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—PPARA—type 2 diabetes mellitus	9.38e-06	3.78e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.3e-06	3.74e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—AKT1—type 2 diabetes mellitus	9.28e-06	3.74e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.26e-06	3.73e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—EGFR—type 2 diabetes mellitus	9.26e-06	3.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PPP2CA—type 2 diabetes mellitus	9.25e-06	3.73e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.23e-06	3.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—type 2 diabetes mellitus	9.22e-06	3.71e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.2e-06	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.2e-06	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.18e-06	3.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AGT—type 2 diabetes mellitus	9.17e-06	3.69e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—AKT1—type 2 diabetes mellitus	9.13e-06	3.67e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—IL6—type 2 diabetes mellitus	9.12e-06	3.67e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.11e-06	3.67e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.1e-06	3.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CCR5—type 2 diabetes mellitus	9.09e-06	3.66e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.08e-06	3.65e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—type 2 diabetes mellitus	9.03e-06	3.64e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.02e-06	3.63e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.99e-06	3.62e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.99e-06	3.62e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—LEP—type 2 diabetes mellitus	8.98e-06	3.62e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APOE—type 2 diabetes mellitus	8.98e-06	3.62e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.95e-06	3.6e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.88e-06	3.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MTHFR—type 2 diabetes mellitus	8.88e-06	3.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GCG—type 2 diabetes mellitus	8.8e-06	3.54e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.8e-06	3.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—type 2 diabetes mellitus	8.79e-06	3.54e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—SRC—type 2 diabetes mellitus	8.72e-06	3.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.66e-06	3.49e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.65e-06	3.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.63e-06	3.47e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.58e-06	3.45e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—SRC—type 2 diabetes mellitus	8.57e-06	3.45e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.49e-06	3.42e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.49e-06	3.42e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—TGFB1—type 2 diabetes mellitus	8.48e-06	3.42e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.47e-06	3.41e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.47e-06	3.41e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HIF1A—type 2 diabetes mellitus	8.47e-06	3.41e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TGFB1—type 2 diabetes mellitus	8.46e-06	3.41e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RELA—type 2 diabetes mellitus	8.46e-06	3.4e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IRS2—type 2 diabetes mellitus	8.45e-06	3.4e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—AKT1—type 2 diabetes mellitus	8.41e-06	3.39e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.35e-06	3.36e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EGFR—type 2 diabetes mellitus	8.32e-06	3.35e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.31e-06	3.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CALM1—type 2 diabetes mellitus	8.3e-06	3.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APOE—type 2 diabetes mellitus	8.27e-06	3.33e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.26e-06	3.32e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.26e-06	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—IL6—type 2 diabetes mellitus	8.25e-06	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APOA1—type 2 diabetes mellitus	8.17e-06	3.29e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.03e-06	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.01e-06	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.94e-06	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SRC—type 2 diabetes mellitus	7.91e-06	3.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—TGFB1—type 2 diabetes mellitus	7.8e-06	3.14e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.77e-06	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—PPARG—type 2 diabetes mellitus	7.76e-06	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.7e-06	3.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS2—type 2 diabetes mellitus	7.7e-06	3.1e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—INS—type 2 diabetes mellitus	7.68e-06	3.09e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.66e-06	3.08e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.66e-06	3.08e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—type 2 diabetes mellitus	7.64e-06	3.08e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.63e-06	3.07e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL6—type 2 diabetes mellitus	7.62e-06	3.07e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—IL6—type 2 diabetes mellitus	7.61e-06	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—AKT1—type 2 diabetes mellitus	7.61e-06	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.59e-06	3.05e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.55e-06	3.04e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.51e-06	3.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AVP—type 2 diabetes mellitus	7.48e-06	3.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.48e-06	3.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.45e-06	3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.42e-06	2.99e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.42e-06	2.99e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.42e-06	2.99e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SRC—type 2 diabetes mellitus	7.4e-06	2.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IRS1—type 2 diabetes mellitus	7.38e-06	2.97e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APOB—type 2 diabetes mellitus	7.23e-06	2.91e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MMP9—type 2 diabetes mellitus	7.21e-06	2.9e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.21e-06	2.9e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.2e-06	2.9e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	7.13e-06	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.12e-06	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—IL6—type 2 diabetes mellitus	7.12e-06	2.86e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SRC—type 2 diabetes mellitus	7.11e-06	2.86e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.07e-06	2.85e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—INS—type 2 diabetes mellitus	7.06e-06	2.84e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.05e-06	2.84e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.03e-06	2.83e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—AKT1—type 2 diabetes mellitus	7.02e-06	2.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.01e-06	2.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SERPINE1—type 2 diabetes mellitus	6.99e-06	2.81e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.93e-06	2.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.91e-06	2.78e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—AKT1—type 2 diabetes mellitus	6.87e-06	2.76e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—AKT2—type 2 diabetes mellitus	6.83e-06	2.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.76e-06	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.73e-06	2.71e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.73e-06	2.71e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SRC—type 2 diabetes mellitus	6.65e-06	2.68e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.62e-06	2.67e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.61e-06	2.66e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—AKT1—type 2 diabetes mellitus	6.57e-06	2.64e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.55e-06	2.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SERPINE1—type 2 diabetes mellitus	6.49e-06	2.61e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.49e-06	2.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.48e-06	2.61e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.47e-06	2.61e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IL6—type 2 diabetes mellitus	6.39e-06	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL6—type 2 diabetes mellitus	6.38e-06	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.36e-06	2.56e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—TGFB1—type 2 diabetes mellitus	6.36e-06	2.56e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.34e-06	2.55e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—type 2 diabetes mellitus	6.23e-06	2.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—C3—type 2 diabetes mellitus	6.22e-06	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3R1—type 2 diabetes mellitus	6.19e-06	2.49e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS3—type 2 diabetes mellitus	6.19e-06	2.49e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.11e-06	2.46e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.95e-06	2.39e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.94e-06	2.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.93e-06	2.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.92e-06	2.38e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.91e-06	2.38e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—AKT1—type 2 diabetes mellitus	5.9e-06	2.37e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.89e-06	2.37e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—AKT1—type 2 diabetes mellitus	5.88e-06	2.37e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IL6—type 2 diabetes mellitus	5.88e-06	2.36e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—AKT1—type 2 diabetes mellitus	5.84e-06	2.35e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.83e-06	2.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.81e-06	2.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.79e-06	2.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.79e-06	2.33e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.77e-06	2.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.72e-06	2.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.71e-06	2.3e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—type 2 diabetes mellitus	5.66e-06	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.46e-06	2.2e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.46e-06	2.2e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—AKT1—type 2 diabetes mellitus	5.42e-06	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.4e-06	2.17e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.35e-06	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.34e-06	2.15e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL6—type 2 diabetes mellitus	5.33e-06	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.33e-06	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.16e-06	2.08e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL6—type 2 diabetes mellitus	4.98e-06	2.01e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.98e-06	2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—INS—type 2 diabetes mellitus	4.95e-06	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—AKT1—type 2 diabetes mellitus	4.94e-06	1.99e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.92e-06	1.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.87e-06	1.96e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.85e-06	1.95e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IL6—type 2 diabetes mellitus	4.79e-06	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.78e-06	1.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.78e-06	1.92e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—AKT1—type 2 diabetes mellitus	4.76e-06	1.92e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.6e-06	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SRC—type 2 diabetes mellitus	4.58e-06	1.84e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.54e-06	1.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—AKT1—type 2 diabetes mellitus	4.54e-06	1.83e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.48e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.45e-06	1.79e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—AKT1—type 2 diabetes mellitus	4.42e-06	1.78e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.36e-06	1.76e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.34e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.34e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.13e-06	1.66e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.11e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TGFB1—type 2 diabetes mellitus	4.1e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.08e-06	1.64e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—type 2 diabetes mellitus	4.02e-06	1.62e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.8e-06	1.53e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.68e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.48e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.44e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.35e-06	1.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.21e-06	1.29e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.12e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.09e-06	1.25e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6—type 2 diabetes mellitus	3.09e-06	1.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—AKT1—type 2 diabetes mellitus	3.07e-06	1.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.87e-06	1.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—AKT1—type 2 diabetes mellitus	2.85e-06	1.15e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.81e-06	1.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.16e-06	8.7e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.99e-06	8.03e-06	CbGpPWpGaD
